ETF·NYSE
State Street Health Care Select Sector SPDR ETF (XLV)
- Net assets
- $43.39B
- Expense ratio
- 0.08%
- Yield
- 1.52%
- 52-week range
- $141.97 $192.32
XLV ETF outlook today
Where XLV stands today, and what CleaRank Financial AI makes of it.
XLV at a glance
State Street Health Care Select Sector SPDR ETF (XLV): Strong Buy, 95/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($173.38 and $159.39).
- Fund Expense ratio 0.08%, $43.4B in net assets, price up 26.6% over 1 year.
Figures as of November 6, 2026.
CleaRank Financial AI
CleaRank rates State Street Health Care Select Sector SPDR ETF (XLV) Strong Buy, with a model score of 95/100.
The trend lifts the score most: the price is 15.94% above its 200-day average and 6.59% above its 50-day average, and the 50-day average is 8.78% above the 200-day. The 50-day average stands at $173.38 and the 200-day at $159.39. Over the past year the price rose 26.63%.
Only on CleaRank
Figures we compute ourselves from XLV's own price history. Tap one to see it in context.
XLV ETF price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $184.80 is 6.6% above the 50-day simple moving average of $173.38.Price above its 200-day average ›
The price is 15.9% above the 200-day simple moving average of $159.39.50-day average above the 200-day ›
The 50-day average ($173.38) is 8.8% above the 200-day average ($159.39), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 85% of its 52-week range, between $141.97 and $192.32.
XLV share price
Pick a period: each tab shows how far XLV has moved over it, to the last close.
Today's trading
Where XLV sits inside today's range and its 52-week range.
XLV fund facts and valuation
What the fund holds, what it costs and how it is valued.
Fund checks
4/5Expense ratio at or below 0.20% ›
The fund charges 0.08% a year, $8.00 on a $10,000 holding.Over $1B in net assets ›
Net assets total $43.4B.One sector above 35% of the fund ›
The largest sector, Healthcare, makes up 100.0% of the fund.Pays a distribution ›
The distribution yield is 1.52%.Price up over one year ›
The price rose 26.63% over the past year, before the fund's 1.52% distribution yield.
XLV Fund Facts
State Street Health Care Select Sector SPDR ETF is a sector-focused exchange-traded fund that provides broad exposure to U.S. health care companies. The fund is designed to track the Health Care Select Sector Index, giving investors access to a diversified mix of large-cap businesses across pharmaceuticals, biotechnology, health care equipment and supplies, health care providers and services, life sciences tools and services, and health care technology.
Sector weights
Total returns to Sep 30, 2026, as the fund family reports them
| Period | XLV |
|---|---|
| YTD | 10.08% |
| 1 month | -0.90% |
| 3 months | 6.44% |
| 1 year | 22.90% |
| 3 years | 11.18% |
| 5 years | 7.48% |
| 10 years | 10.69% |
As of Nov 8, 2026, XLV has an expense ratio of 0.08%, $43.39B in net assets and a distribution yield of 1.52%.
Fund reference data as of Nov 8, 2026. Expense ratio and net assets are reported by the fund. The trailing returns are the fund family's own month-end total returns, to Sep 30, 2026, with distributions included, so they can differ from the price changes elsewhere on this page.
Key statistics
The headline figures for XLV.
What the numbers say
CleaRank Financial AI's reading of XLV's holdings, performance and risks.
Healthcare makes up 100.0% of the fund, so XLV moves almost entirely with that one sector. XLV is a Health fund run by State Street Investment Management and was launched on December 16, 1998.
Owning XLV carries an annual expense ratio of 0.08%, which comes to $8.00 a year on every $10,000 placed in the fund. The fund's net assets total $43.4B, and its distribution yield is 1.52%. Portfolio turnover is 2%.
XLV's typical daily move is 1.30%. With 100.0% of its holdings in Healthcare, the fund depends heavily on one sector.
XLV AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 62.9, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 62.9 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of XLV
The score, the reasoning behind it, and what could move the price next.
Trading at $184.80, State Street Health Care Select Sector SPDR ETF (XLV) holds above both of its main moving averages: 6.59% above the 50-day ($173.38) and 15.94% above the 200-day ($159.39). The price sits near the top of its 52-week range, 3.91% below the high of $192.32 and 30.17% above the low of $141.97. With the 50-day average 8.78% above the 200-day, the averages themselves are lined up for an uptrend.
The 14-day RSI of 62.9 is in the bullish zone, below the overbought line, and the MACD line is positive. The price is up over each of these periods: 9.47% over the past month, 11.54% over the past three months and 26.63% over the past year.
- Two levels matter most here: the 52-week high at $192.32 sits above the price, and the 20-day EMA at $180.48 sits below it.
- A 14-day RSI of 62.9 falls in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- Costs compound: at 0.08% a year, XLV charges $8.00 on every $10,000 invested.
The uptrend rests on XLV staying above its 50-day average at $173.38 and its 200-day average at $159.39; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $180.48.
XLV's next level overhead is the 52-week high of $192.32. The RSI sits in the bullish zone, which is the momentum behind the current move.
Technical indicators
Momentum and trend for XLV, from its daily closes.
As of November 6, 2026, with XLV at $184.80, its 14-day RSI is 62.9 (showing bullish momentum without being overbought), its 50-day simple moving average is $173.38 and its 200-day is $159.39.
Calculated by CleaRank on daily closes as of November 6, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What XLV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 6, 2026, XLV's 1-year correlation of daily returns is +0.42 with S&P 500 (SPY), +0.23 with Nasdaq 100 (QQQ), +0.09 with Bitcoin (BTC) and +0.09 with gold (XAU).
XLV risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much XLV tends to move, against the market and on its own.
XLV price history and drawdowns
XLV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Typical daily move under 2% ›
A typical daily move is 1.30% (the standard deviation of the last 30 daily returns).Recovered from its worst fall ›
The worst fall was 28.2%, from January 2020 to March 2020, regained by July 2020.Most 1-year holds ended higher ›
84% of 1-year holding periods in the last 10 years ended with a gain.Trailed the S&P 500 since December 2016 ›
$10,000 invested in December 2016 is now worth $31,986, against $39,188 in the S&P 500 (SPY).
XLV Drawdowns & Recovery
As of November 6, 2026, XLV's worst peak-to-trough fall over the last 10 years with dividends reinvested was -28.2% (January 2020 to March 2020); it regained that peak by July 2020, 4 months after the low, and 84% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into XLV in December 2016 is worth now, against the same amount in the S&P 500.
Against the market: XLV trailed the S&P 500 over this period: $31,986 against $39,188.
A $10,000 investment in XLV in December 2016 would be worth about $31,986 today with dividends reinvested, compared with about $39,188 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to XLV, and which have not.
Strongest month, November: an average of +4.10%, up in 7 of 9 years.
Weakest month, September: an average of -1.47%, up in 2 of 10 years.
This month, November: has averaged +4.10%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Across 10 calendar years of history, XLV's strongest calendar month has been November (average +4.10%, up in 7 of 9 years) and its weakest September (average -1.47%, up in 2 of 10 years).
Average return for each calendar month across 10 calendar years of history, from weekly closing prices with dividends included.
XLV long-term scenarios 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in XLV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in XLV today could grow to about $13,558 by 2030 in the base case, with a 90th-percentile outcome near $20,876 and a 10th-percentile outcome around $8,806. The simulation models price only; at today's 1.52% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
XLV 2030 Scenarios (Monte Carlo)
The same simulation in prices, year by year.
CleaRank's simulation projects a price near $251 for XLV by 2030 in the base case, from $185 today (1.4x over 4 years). The 10th-percentile path ends near $163. These are outcomes of a Monte Carlo simulation run on XLV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $161 | $199 | $247 | |
| 2028 | $159 | $215 | $292 | |
| 2029 | $160 | $232 | $337 | |
| 2030 | $163 | $251 | $386 |
Method: a lognormal simulation of XLV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
XLV ETF outlook: questions people ask
Answered from the figures on this page, as of November 6, 2026.